European Commission approves Yselty (linzagolix) for the symptomatic treatment of endometriosis – Theramex
Theramex, a global pharmaceutical company dedicated to women’s health, is pleased to announce that the European Commission (EC) has approved an extended indication for Yselty (linzagolix), an oral… read more.
